Article
Breakingviews - Lonza's CEO churn adds to company's ailments
Rating:
0.0
Views:
41
Likes:
1
Library:
1
Lonza's new broom will face even more challenges than its old one. On Monday, the $38 billion manufacturer of drug ingredients said Chief Executive Pierre-Alain Ruffieux will leave the Swiss company and be replaced by Chairman Albert Baehny until a successor is found. A 10% share price slump suggests investors worry that his exit makes it more likely the group's new targets, due later this year, will disappoint.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value